Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

• Κύριοι συγγραφείς: Chen CC (Συγγραφέας), Rane PB (Συγγραφέας), Hines DM (Συγγραφέας), Patel J (Συγγραφέας), Harrison DJ (Συγγραφέας), Wade RL (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Dove Medical Press, 2018-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Chi-Chang Chen,1 Pallavi B Rane,2 Dionne M Hines,1 Jeetvan Patel,2 David J Harrison,2 Rolin L Wade1 1IQVIA, Plymouth Meeting, PA, USA; 2Amgen Inc., Thousand Oaks, CA, USA Background: This study evaluated the proportion of patients with atherosclerotic cardiovascular disease (ASCVD) and probable hete...